Holen Sie sich die Stockscreener-App
39.19
3.14%
-1.24
Handel nachbörslich:
39.18
-0.010
-0.03%
Schlusskurs vom Vortag:
$40.43
Offen:
$40.4
24-Stunden-Volumen:
5.58M
Relative Volume:
0.79
Marktkapitalisierung:
$19.27B
Einnahmen:
$178.19B
Nettoeinkommen (Verlust:
$2.05B
KGV:
9.6892
EPS:
4.0447
Netto-Cashflow:
$1.08B
1W Leistung:
-1.90%
1M Leistung:
-15.59%
6M Leistung:
+49.64%
1J Leistung:
-30.63%
1-Tages-Spanne:
$39.00
$40.83
1-Wochen-Bereich:
$36.06
$40.83
52-Wochen-Spanne:
$25.07
$66.03
Centene Corp Stock (CNC) Company Profile
Firmenname
Centene Corp
Sektor
Branche
Telefon
(314) 725-4477
Adresse
7700 FORSYTH BLVD., ST LOUIS
Compare CNC vs UNH, CVS, CI, ELV, HUM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CNC
Centene Corp
|
39.18 | 19.88B | 178.19B | 2.05B | 1.08B | 4.0447 |
|
UNH
Unitedhealth Group Inc
|
284.49 | 252.65B | 447.57B | 12.81B | 16.08B | 13.19 |
|
CVS
Cvs Health Corp
|
77.91 | 97.99B | 402.11B | 1.73B | 7.81B | 1.3789 |
|
CI
Cigna Group
|
287.49 | 77.65B | 216.66B | 6.25B | 7.44B | 22.19 |
|
ELV
Elevance Health Inc
|
336.04 | 72.89B | 199.13B | 5.66B | 3.17B | 25.11 |
|
HUM
Humana Inc
|
179.00 | 21.10B | 126.36B | 1.30B | 1.55B | 10.67 |
Centene Corp Stock (CNC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-05 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2025-10-14 | Eingeleitet | Goldman | Sell |
| 2025-07-28 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2025-07-23 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2025-07-21 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-07-16 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2025-07-10 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-07-02 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-07-02 | Herabstufung | UBS | Buy → Neutral |
| 2025-06-09 | Fortgesetzt | Morgan Stanley | Overweight |
| 2025-06-02 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2025-04-08 | Hochstufung | Jefferies | Underperform → Hold |
| 2025-02-06 | Herabstufung | Argus | Buy → Hold |
| 2024-12-17 | Fortgesetzt | JP Morgan | Overweight |
| 2024-12-13 | Hochstufung | UBS | Neutral → Buy |
| 2024-12-10 | Herabstufung | Jefferies | Hold → Underperform |
| 2024-07-24 | Herabstufung | Jefferies | Buy → Hold |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Neutral |
| 2024-03-21 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2024-03-06 | Eingeleitet | Barclays | Overweight |
| 2024-01-02 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-09-05 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2023-08-30 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-07-12 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2023-06-20 | Eingeleitet | UBS | Neutral |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-03-08 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2023-02-23 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-12-13 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-09-30 | Eingeleitet | Argus | Buy |
| 2022-08-26 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-07-28 | Fortgesetzt | Barclays | Overweight |
| 2022-07-14 | Hochstufung | Jefferies | Hold → Buy |
| 2022-06-21 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2022-06-17 | Eingeleitet | Loop Capital | Buy |
| 2022-05-27 | Fortgesetzt | Bernstein | Outperform |
| 2022-05-26 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-01-07 | Fortgesetzt | Barclays | Overweight |
| 2022-01-06 | Fortgesetzt | JP Morgan | Overweight |
| 2021-12-14 | Eingeleitet | Goldman | Neutral |
| 2021-12-13 | Bestätigt | BMO Capital Markets | Outperform |
| 2021-12-13 | Bestätigt | BofA Securities | Buy |
| 2021-12-13 | Bestätigt | Credit Suisse | Neutral |
| 2021-12-13 | Bestätigt | Mizuho | Neutral |
| 2021-12-13 | Bestätigt | Oppenheimer | Outperform |
| 2021-12-13 | Bestätigt | Stephens | Overweight |
| 2021-12-13 | Bestätigt | Truist | Buy |
| 2021-12-13 | Bestätigt | Wells Fargo | Overweight |
| 2021-12-13 | Bestätigt | Wolfe Research | Outperform |
| 2021-11-01 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-09-10 | Eingeleitet | Cowen | Outperform |
| 2021-07-09 | Eingeleitet | Seaport Global Securities | Buy |
| 2021-05-19 | Eingeleitet | Wells Fargo | Overweight |
| 2021-05-11 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2021-03-10 | Eingeleitet | Mizuho | Neutral |
| 2021-01-21 | Fortgesetzt | Goldman | Neutral |
| 2021-01-15 | Herabstufung | Jefferies | Buy → Hold |
| 2020-09-22 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2020-07-01 | Eingeleitet | SVB Leerink | Outperform |
| 2020-02-05 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-02-03 | Fortgesetzt | Evercore ISI | Outperform |
| 2020-01-28 | Bestätigt | Bernstein | Outperform |
| 2020-01-06 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Buy |
| 2019-05-10 | Hochstufung | Citigroup | Neutral → Buy |
| 2019-01-14 | Eingeleitet | Stephens | Overweight |
| 2018-10-24 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
| 2018-07-18 | Fortgesetzt | Citigroup | Neutral |
| 2017-12-18 | Bestätigt | Jefferies | Buy |
| 2017-09-13 | Bestätigt | Leerink Partners | Mkt Perform |
| 2017-06-07 | Eingeleitet | Morgan Stanley | Overweight |
| 2017-05-22 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2017-04-05 | Eingeleitet | Deutsche Bank | Buy |
| 2017-03-23 | Herabstufung | Citigroup | Buy → Neutral |
| 2017-02-08 | Bestätigt | Barclays | Overweight |
| 2017-02-07 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2017-01-04 | Eingeleitet | Piper Jaffray | Overweight |
Alle ansehen
Centene Corp Aktie (CNC) Neueste Nachrichten
Ambetter Health Celebrates Completion of New Playground at Southeast Park - Finviz
Centene’s 2025 Loss and 2026 Outlook Could Be A Game Changer For Centene (CNC) - Yahoo Finance
TD Cowen Issues Positive Forecast for Centene (NYSE:CNC) Stock Price - MarketBeat
20 Texas Schools Partner with Superior HealthPlan and The Centene Foundation to Address Social Isolation with No One Eats Alone Initiative - Finviz
More than 1 million students join 'No One Eats Alone' to fight school loneliness - Stock Titan
Morgan Stanley Maintains a Hold on Centene Corporation (CNC) - Yahoo Finance
Centene Takes A Hit As Medicaid Membership Shrinks - AOL.com
Centene Says Behavioral Health Accounts for Half of Excess Costs - Behavioral Health Business
Demystifying Centene: Insights From 5 Analyst Reviews - Benzinga
Truist Securities reiterates Buy rating on Centene stock with $47 target - Investing.com UK
Centene (CNC) Analyst Rating Reiterated as Neutral by Cantor Fit - GuruFocus
Cantor Fitzgerald maintains Neutral rating on Centene stock amid challenging outlook - Investing.com
Centene’s Stock Is Down 12% in 2026: Can the 2026 Rebound Story Work? - TIKR.com
Centene Corporation (NYSE:CNC) Q4 2025 Earnings Call Transcript - Insider Monkey
Centene Corp (CNC) Q4 2025 Earnings Call Highlights: Navigating Challenges and Setting Sights on 2026 Growth - GuruFocus
Centene stock slides as 2026 profit view beats estimates but revenue forecast falls short - TechStock²
Centene (CNC) Projects Over 40% EPS Growth for 2026 - GuruFocus
Centene Incurs Q4 Loss, Revenues Up YoY due to PDP Business Strength - Barchart.com
Centene (NYSE:CNC) Releases Quarterly Earnings Results, Beats Expectations By $0.03 EPS - MarketBeat
Centene posts $6.6B loss as health care giant grapples with rising medical costs - The Business Journals
Centene Releases 2026 Profit Outlook Above Estimates as Shares F - GuruFocus
Philip Morris Beats Estimates as Smoke-Free Products Drive Earnings Momentum - Investing.com
Centene Releases 2026 Profit Outlook Above Estimates as Shares Fall 6% - TradingView
Earnings call transcript: Centene Corp Q4 2025 reveals EPS beat, stock drops - Investing.com
Centene 2026 guidance slides: 40% EPS growth target despite revenue headwinds - Investing.com
Savant Capital LLC Increases Stock Holdings in Centene Corporation $CNC - MarketBeat
Centene’s 2026 profit forecast tops Wall Street expectations - Modern Healthcare News
Centene (CNC) Beats Q4 Earnings Expectations with Strong Revenue Growth - GuruFocus
Centene (CNC) Surpasses 2026 Profit Expectations Despite Q4 Chal - GuruFocus
Centene (NYSE:CNC) Surprises With Q4 CY2025 Sales - Finviz
CENTENE CORP (NYSE:CNC) Stock Falls on Mixed 2025 Results Despite Strong 2026 Guidance - ChartMill
Centene (CNC) Reports Q4 Loss, Beats Revenue Estimates - Yahoo Finance
Centene: Q4 Earnings Snapshot - kens5.com
Centene’s 2026 Profit Forecast Tops Wall Street Expectations - Bloomberg.com
Centene (CNC) Projects FY26 Revenue Slightly Below Consensus - GuruFocus
Centene (CNC) Reports Strong Q4 Revenue Exceeding Expectations - GuruFocus
Centene: Fourth Quarter Earnings Overview - Bitget
Centene shares drop nearly 3% as Q4 loss overshadows revenue beat - Investing.com
Centene Corporation Reports 2025 Results and Announces 2026 Guidance - TradingView
Centene’s 2026 Profit Forecast Beats Wall Street Expectations - Bloomberg
Centene Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts - Benzinga
Centene (CNC) Set to Announce Q4 Earnings with Mixed Expectations - GuruFocus
Exploring Centene's Earnings Expectations - Benzinga
Centene (CNC) Q4 Earnings: What To Expect - Finviz
Centene Corporation (CNC): A Bull Case Theory - Finviz
Can Centene's Q4 Earnings Escape Membership & Cost Headwinds? - Finviz
Agree To Buy Centene At $20, Earn 6% Using Options - Nasdaq
Top Superinvestors Are Buying Centene Corp (CNC) - The Acquirer's Multiple
Palmetto Grain Brokerage - Palmetto Grain Brokerage
Are Wall Street Analysts Bullish on Centene Stock? - Barchart.com
Centene expands palliative care access in Ohio through Tuesday Health - MSN
Finanzdaten der Centene Corp-Aktie (CNC)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.01%
1.74%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):